Literature DB >> 10716685

Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease.

J Grove1, A K Daly, M F Bassendine, E Gilvarry, C P Day.   

Abstract

BACKGROUND: The factors determining why less than 10% of heavy drinkers develop advanced alcoholic liver disease (ALD) remain elusive, although genetic factors may be important. Interleukin 10 (IL-10) is an important cytokine with anti-inflammatory, anti-immune, and antifibrotic functions. Several polymorphisms have been identified in the IL-10 promoter and recent evidence suggests that some of these may have functional effects on IL-10 secretion. AIMS: To test the hypothesis that IL-10 promoter region polymorphisms are associated with susceptibility to ALD.
METHODS: The allele frequencies for the two single base pair substitutions at positions -627 (C-->A) and -1117 (A-->G) in the IL-10 promoter were determined in 287 heavy drinkers with biopsy proved advanced ALD, 107 heavy drinkers with no evidence of liver disease or steatosis only on biopsy, and 227 local healthy volunteers.
RESULTS: At position -627, 50% of patients with advanced ALD had a least one A allele compared with 33% of controls (p<0.0001) and 34% of drinkers with no or mild disease (p=0.017). At position -1117, the slight excess of the A allele in drinkers with advanced disease was because of linkage disequilibrium between the A alleles at the two sites.
CONCLUSIONS: Among heavy drinkers, possession of the A allele at position -627 in the IL-10 promoter is associated with an increased risk of advanced liver disease. This is consistent with recent functional data that the -627*A allele is associated with low IL-10 expression which will favour inflammatory, immune mediated, and profibrotic mechanisms of alcohol related liver injury.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10716685      PMCID: PMC1727883          DOI: 10.1136/gut.46.4.540

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  48 in total

1.  No evidence for involvement of type 1 collagen structural genes in 'genetic predisposition' to alcoholic cirrhosis.

Authors:  R Bashir; C P Day; O F James; D J Ogilvie; B Sykes; M F Bassendine
Journal:  J Hepatol       Date:  1992-11       Impact factor: 25.083

2.  An investigation of polymorphism in the interleukin-10 gene promoter.

Authors:  D M Turner; D M Williams; D Sankaran; M Lazarus; P J Sinnott; I V Hutchinson
Journal:  Eur J Immunogenet       Date:  1997-02

3.  Hepatoprotective role of interleukin 10 in galactosamine/lipopolysaccharide mouse liver injury.

Authors:  H Louis; O Le Moine; M O Peny; B Gulbis; F Nisol; M Goldman; J Devière
Journal:  Gastroenterology       Date:  1997-03       Impact factor: 22.682

4.  In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha.

Authors:  R T Gazzinelli; M Wysocka; S Hieny; T Scharton-Kersten; A Cheever; R Kühn; W Müller; G Trinchieri; A Sher
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

5.  Genetic predisposition to organ-specific endpoints of alcoholism.

Authors:  T Reed; W F Page; R J Viken; J C Christian
Journal:  Alcohol Clin Exp Res       Date:  1996-12       Impact factor: 3.455

6.  Effect of chronic coadministration of endotoxin and ethanol on rat liver pathology and proinflammatory and anti-inflammatory cytokines.

Authors:  H A Järveläinen; C Fang; M Ingelman-Sundberg; K O Lindros
Journal:  Hepatology       Date:  1999-05       Impact factor: 17.425

7.  Interleukin-10 regulation in normal subjects and patients with asthma.

Authors:  L Borish; A Aarons; J Rumbyrt; P Cvietusa; J Negri; S Wenzel
Journal:  J Allergy Clin Immunol       Date:  1996-06       Impact factor: 10.793

8.  Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.

Authors:  F Rousset; E Garcia; T Defrance; C Péronne; N Vezzio; D H Hsu; R Kastelein; K W Moore; J Banchereau
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

9.  Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production.

Authors:  G Del Prete; M De Carli; F Almerigogna; M G Giudizi; R Biagiotti; S Romagnani
Journal:  J Immunol       Date:  1993-01-15       Impact factor: 5.422

10.  IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury.

Authors:  T Arai; K Hiromatsu; N Kobayashi; M Takano; H Ishida; Y Nimura; Y Yoshikai
Journal:  J Immunol       Date:  1995-12-15       Impact factor: 5.422

View more
  29 in total

Review 1.  Candidate gene case-control association studies: advantages and potential pitfalls.

Authors:  A K Daly; C P Day
Journal:  Br J Clin Pharmacol       Date:  2001-11       Impact factor: 4.335

Review 2.  Genetics of liver disease: immunogenetics and disease pathogenesis.

Authors:  P T Donaldson
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

3.  β-Hydroxybutyrate protects from alcohol-induced liver injury via a Hcar2-cAMP dependent pathway.

Authors:  Yonglin Chen; Xinshou Ouyang; Rafaz Hoque; Irma Garcia-Martinez; Muhammad Nadeem Yousaf; Sarah Tonack; Stefan Offermanns; Laurent Dubuquoy; Alexandre Louvet; Philippe Mathurin; Veronica Massey; Bernd Schnabl; Ramon Alberola Bataller; Wajahat Zafar Mehal
Journal:  J Hepatol       Date:  2018-04-27       Impact factor: 25.083

Review 4.  Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Shilu Mathew; Hany Abdel-Hafiz; Abbas Raza; Kaneez Fatima; Ishtiaq Qadri
Journal:  World J Hepatol       Date:  2016-04-08

5.  Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice.

Authors:  Andrew M Miller; Hua Wang; Adeline Bertola; Ogyi Park; Norio Horiguchi; Sung Hwan Ki; Shi Yin; Fouad Lafdil; Bin Gao
Journal:  Hepatology       Date:  2011-09-02       Impact factor: 17.425

6.  Alcoholic Liver Disease in Asia, Europe, and North America.

Authors:  Suthat Liangpunsakul; Paul Haber; Geoffrey W McCaughan
Journal:  Gastroenterology       Date:  2016-02-27       Impact factor: 22.682

Review 7.  Interleukin-10 and chronic liver disease.

Authors:  Li-Juan Zhang; Xiao-Zhong Wang
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

Review 8.  The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?

Authors:  Luca Valenti; Anna Ludovica Fracanzani; Silvia Fargion
Journal:  Semin Immunopathol       Date:  2009-05-14       Impact factor: 9.623

9.  Interleukin-10 gene -627 allele variants, not interleukin-I beta gene and receptor antagonist gene polymorphisms, are associated with atopic bronchial asthma.

Authors:  Liang-Wen Hang; Te-Chun Hsia; Wen-Chi Chen; Huey-Yi Chen; Jeffrey J P Tsai; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

10.  Role of host genetics in fibrosis.

Authors:  Georgina L Hold; Paraskevi Untiveros; Karin A Saunders; Emad M El-Omar
Journal:  Fibrogenesis Tissue Repair       Date:  2009-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.